Advanced Search (OLGA)

Gene: RAVER2 (ribonucleoprotein, PTB binding 2) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

RAVER2

Name:

ribonucleoprotein, PTB binding 2

RGD ID:

1602482

HGNC Page

HGNC:25577

Description:

Enables RNA binding activity. Predicted to be located in cytoplasm and nucleus.

Type:

protein-coding

RefSeq Status:

VALIDATED

Previously known as:

DKFZp762D1011; FLJ10770; KIAA1579; protein raver-2; ribonucleoprotein PTB-binding 2; ribonucleoprotein, PTB-binding 2

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	1	64,745,075 - 64,833,232 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	1	64,745,075 - 64,833,232 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	1	65,210,758 - 65,298,915 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	1	64,983,366 - 65,071,500 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	1	63,501,670 - 63,589,801 (+)	NCBI		Celera
Cytogenetic Map	1	p31.3	NCBI
HuRef	1	63,319,747 - 63,407,824 (+)	NCBI		HuRef
CHM1_1	1	65,327,123 - 65,415,262 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	1	64,623,084 - 64,711,231 (+)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RAVER2	Human	congenital disorder of glycosylation It		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: PGM1-congenital disorder of glycosylation	ClinVar	PMID:28492532
RAVER2	Human	intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability and severe	ClinVar	PMID:25741868

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RAVER2	Human	1,2-dimethylhydrazine	increases expression	ISO	Raver2 (Mus musculus)	6480464	1 and 2-Dimethylhydrazine results in increased expression of RAVER2 mRNA	CTD	PMID:22206623
RAVER2	Human	17beta-estradiol	multiple interactions	ISO	Raver2 (Rattus norvegicus)	6480464	[Testosterone co-treated with Estradiol] results in increased expression of RAVER2 mRNA	CTD	PMID:32741896
RAVER2	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		6480464	Tetrachlorodibenzodioxin results in decreased expression of RAVER2 mRNA	CTD	PMID:20106945 and PMID:21632981
RAVER2	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	Raver2 (Mus musculus)	6480464	Tetrachlorodibenzodioxin affects the expression of RAVER2 mRNA	CTD	PMID:24680724
RAVER2	Human	6-propyl-2-thiouracil	increases expression	ISO	Raver2 (Rattus norvegicus)	6480464	Propylthiouracil results in increased expression of RAVER2 mRNA	CTD	PMID:24780913
RAVER2	Human	6-propyl-2-thiouracil	decreases expression	ISO	Raver2 (Rattus norvegicus)	6480464	Propylthiouracil results in decreased expression of RAVER2 mRNA	CTD	PMID:30047161
RAVER2	Human	acrolein	multiple interactions	EXP		6480464	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of RAVER2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of RAVER2 mRNA	CTD	PMID:32699268
RAVER2	Human	all-trans-retinoic acid	decreases expression	EXP		6480464	Tretinoin results in decreased expression of RAVER2 mRNA	CTD	PMID:33167477
RAVER2	Human	alpha-pinene	multiple interactions	EXP		6480464	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of RAVER2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of RAVER2 mRNA	CTD	PMID:32699268
RAVER2	Human	amitrole	decreases expression	ISO	Raver2 (Rattus norvegicus)	6480464	Amitrole results in decreased expression of RAVER2 mRNA	CTD	PMID:30047161
RAVER2	Human	antirheumatic drug	increases expression	EXP		6480464	Antirheumatic Agents results in increased expression of RAVER2 mRNA	CTD	PMID:24449571
RAVER2	Human	aristolochic acid A	decreases expression	EXP		6480464	aristolochic acid I results in decreased expression of RAVER2 mRNA	CTD	PMID:33212167
RAVER2	Human	arsane	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAVER2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RAVER2 mRNA	CTD	PMID:39836092
RAVER2	Human	arsenic atom	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAVER2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RAVER2 mRNA	CTD	PMID:39836092
RAVER2	Human	benzo[a]pyrene	decreases expression	ISO	Raver2 (Mus musculus)	6480464	Benzo(a)pyrene results in decreased expression of RAVER2 mRNA	CTD	PMID:21569818
RAVER2	Human	benzo[a]pyrene	decreases expression	EXP		6480464	Benzo(a)pyrene results in decreased expression of RAVER2 mRNA	CTD	PMID:22316170
RAVER2	Human	benzo[a]pyrene diol epoxide I	increases expression	EXP		6480464	7 more ...	CTD	PMID:26238291
RAVER2	Human	bisphenol A	decreases expression	ISO	Raver2 (Rattus norvegicus)	6480464	bisphenol A results in decreased expression of RAVER2 mRNA	CTD	PMID:25181051 more ...
RAVER2	Human	bisphenol A	multiple interactions	EXP		6480464	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RAVER2 gene	CTD	PMID:31601247
RAVER2	Human	butanal	decreases expression	EXP		6480464	butyraldehyde results in decreased expression of RAVER2 mRNA	CTD	PMID:26079696
RAVER2	Human	carbon nanotube	decreases expression	ISO	Raver2 (Mus musculus)	6480464	Nanotubes more ...	CTD	PMID:25554681
RAVER2	Human	clobetasol	increases expression	ISO	Raver2 (Mus musculus)	6480464	Clobetasol results in increased expression of RAVER2 mRNA	CTD	PMID:27462272
RAVER2	Human	copper atom	multiple interactions	EXP		6480464	[NSC 689534 binds to Copper] which results in decreased expression of RAVER2 mRNA	CTD	PMID:20971185
RAVER2	Human	copper(0)	multiple interactions	EXP		6480464	[NSC 689534 binds to Copper] which results in decreased expression of RAVER2 mRNA	CTD	PMID:20971185
RAVER2	Human	corosolic acid	decreases expression	EXP		6480464	corosolic acid results in decreased expression of RAVER2 mRNA	CTD	PMID:37939859
RAVER2	Human	cyclosporin A	decreases expression	EXP		6480464	Cyclosporine results in decreased expression of RAVER2 mRNA	CTD	PMID:20106945 and PMID:25562108
RAVER2	Human	Dibutyl phosphate	affects expression	EXP		6480464	di-n-butylphosphoric acid affects the expression of RAVER2 mRNA	CTD	PMID:37042841
RAVER2	Human	dorsomorphin	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAVER2 mRNA	CTD	PMID:27188386
RAVER2	Human	doxorubicin	decreases expression	EXP		6480464	Doxorubicin results in decreased expression of RAVER2 mRNA	CTD	PMID:29803840
RAVER2	Human	enzyme inhibitor	multiple interactions	EXP		6480464	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RAVER2 protein	CTD	PMID:23301498
RAVER2	Human	folic acid	decreases expression	ISO	Raver2 (Mus musculus)	6480464	Folic Acid results in decreased expression of RAVER2 mRNA	CTD	PMID:25629700
RAVER2	Human	fulvestrant	multiple interactions	EXP		6480464	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RAVER2 gene	CTD	PMID:31601247
RAVER2	Human	gallic acid	decreases expression	EXP		6480464	Gallic Acid results in decreased expression of RAVER2 mRNA	CTD	PMID:34408198
RAVER2	Human	genistein	increases methylation	ISO	Raver2 (Rattus norvegicus)	6480464	Genistein results in increased methylation of RAVER2 gene	CTD	PMID:28505145
RAVER2	Human	gentamycin	decreases expression	ISO	Raver2 (Rattus norvegicus)	6480464	Gentamicins results in decreased expression of RAVER2 mRNA	CTD	PMID:33387578
RAVER2	Human	manganese atom	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAVER2 mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RAVER2 mRNA	CTD	PMID:39836092
RAVER2	Human	manganese(0)	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAVER2 mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RAVER2 mRNA	CTD	PMID:39836092
RAVER2	Human	manganese(II) chloride	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAVER2 mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RAVER2 mRNA	CTD	PMID:39836092
RAVER2	Human	methimazole	decreases expression	ISO	Raver2 (Rattus norvegicus)	6480464	Methimazole results in decreased expression of RAVER2 mRNA	CTD	PMID:30047161
RAVER2	Human	methylmercury chloride	decreases expression	EXP		6480464	methylmercuric chloride results in decreased expression of RAVER2 mRNA	CTD	PMID:28001369
RAVER2	Human	nickel sulfate	increases expression	EXP		6480464	nickel sulfate results in increased expression of RAVER2 mRNA	CTD	PMID:22714537
RAVER2	Human	ozone	multiple interactions	EXP		6480464	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of RAVER2 mRNA more ...	CTD	PMID:32699268
RAVER2	Human	ozone	multiple interactions	ISO	Raver2 (Mus musculus)	6480464	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RAVER2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RAVER2 mRNA	CTD	PMID:27106289 and PMID:34911549
RAVER2	Human	paracetamol	increases expression	ISO	Raver2 (Rattus norvegicus)	6480464	Acetaminophen results in increased expression of RAVER2 mRNA	CTD	PMID:33387578
RAVER2	Human	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	Raver2 (Mus musculus)	6480464	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RAVER2 mRNA	CTD	PMID:36331819
RAVER2	Human	potassium chromate	increases expression	EXP		6480464	potassium chromate(VI) results in increased expression of RAVER2 mRNA	CTD	PMID:22714537
RAVER2	Human	quercetin	decreases expression	EXP		6480464	Quercetin results in decreased expression of RAVER2 mRNA	CTD	PMID:21632981
RAVER2	Human	SB 431542	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAVER2 mRNA	CTD	PMID:27188386
RAVER2	Human	sodium arsenite	increases expression	EXP		6480464	sodium arsenite results in increased expression of RAVER2 mRNA	CTD	PMID:22714537
RAVER2	Human	sodium arsenite	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAVER2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RAVER2 mRNA	CTD	PMID:39836092
RAVER2	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of RAVER2 mRNA	CTD	PMID:38568856
RAVER2	Human	sunitinib	increases expression	EXP		6480464	Sunitinib results in increased expression of RAVER2 mRNA	CTD	PMID:31533062
RAVER2	Human	testosterone	multiple interactions	ISO	Raver2 (Rattus norvegicus)	6480464	[Testosterone co-treated with Estradiol] results in increased expression of RAVER2 mRNA	CTD	PMID:32741896
RAVER2	Human	thiram	decreases expression	EXP		6480464	Thiram results in decreased expression of RAVER2 mRNA	CTD	PMID:38568856
RAVER2	Human	titanium dioxide	decreases methylation	ISO	Raver2 (Mus musculus)	6480464	titanium dioxide results in decreased methylation of RAVER2 gene and titanium dioxide results in decreased methylation of RAVER2 promoter	CTD	PMID:35295148
RAVER2	Human	trichloroethene	increases expression	ISO	Raver2 (Rattus norvegicus)	6480464	Trichloroethylene results in increased expression of RAVER2 mRNA	CTD	PMID:33387578
RAVER2	Human	trichostatin A	decreases expression	EXP		6480464	trichostatin A results in decreased expression of RAVER2 mRNA	CTD	PMID:26272509
RAVER2	Human	trichostatin A	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAVER2 mRNA	CTD	PMID:27188386
RAVER2	Human	triptonide	increases expression	ISO	Raver2 (Mus musculus)	6480464	triptonide results in increased expression of RAVER2 mRNA	CTD	PMID:33045310
RAVER2	Human	valproic acid	affects expression	EXP		6480464	Valproic Acid affects the expression of RAVER2 mRNA	CTD	PMID:25979313
RAVER2	Human	valproic acid	decreases expression	EXP		6480464	Valproic Acid results in decreased expression of RAVER2 mRNA	CTD	PMID:23179753 more ...

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RAVER2	Human	cytoplasm	located_in	IEA	UniProtKB-KW:KW-0963	150520179		UniProt	GO_REF:0000043
RAVER2	Human	cytoplasm	located_in	IEA	UniProtKB-SubCell:SL-0086	150520179		UniProt	GO_REF:0000044
RAVER2	Human	nucleus	located_in	IEA	UniProtKB:Q7TPD6 and ensembl:ENSMUSP00000043142	150520179		Ensembl	GO_REF:0000107
RAVER2	Human	nucleus	located_in	IEA	UniProtKB-KW:KW-0539	150520179		UniProt	GO_REF:0000043
RAVER2	Human	nucleus	located_in	IEA	UniProtKB-SubCell:SL-0191	150520179		UniProt	GO_REF:0000044

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RAVER2	Human	nucleic acid binding	enables	IEA	InterPro:IPR035979	150520179		InterPro	GO_REF:0000002
RAVER2	Human	protein binding	enables	ISO	PR:P17225	9068941	PMID:16051233	MGI	PMID:16051233
RAVER2	Human	RNA binding	enables	IBA	MGI:1913895 more ...	150520179		GO_Central	GO_REF:0000033
RAVER2	Human	RNA binding	enables	IEA	InterPro:IPR000504	150520179		InterPro	GO_REF:0000002
RAVER2	Human	RNA binding	enables	IEA	UniProtKB-KW:KW-0694	150520179		UniProt	GO_REF:0000043
RAVER2	Human	RNA binding	enables	HDA		150520179	PMID:22658674 and PMID:22681889	UniProt	PMID:22658674 and PMID:22681889

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RAVER2	Human	Intellectual disability, severe		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability and severe	ClinVar	PMID:25741868

#	Reference Title	Reference Citation
1.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:10997877	PMID:12477932	PMID:14702039	PMID:15489334	PMID:16051233	PMID:20237496	PMID:21873635	PMID:22146317	PMID:22561236	PMID:22658674	PMID:22681889	PMID:25637521
PMID:26186194	PMID:26496610	PMID:26972000	PMID:28514442	PMID:29395067	PMID:30737378	PMID:32344865	PMID:33961781	PMID:34079125	PMID:35198878	PMID:35439318	PMID:35831314
PMID:37689310

RAVER2
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	1	64,745,075 - 64,833,232 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	1	64,745,075 - 64,833,232 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	1	65,210,758 - 65,298,915 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	1	64,983,366 - 65,071,500 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	1	63,501,670 - 63,589,801 (+)	NCBI		Celera
Cytogenetic Map	1	p31.3	NCBI
HuRef	1	63,319,747 - 63,407,824 (+)	NCBI		HuRef
CHM1_1	1	65,327,123 - 65,415,262 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	1	64,623,084 - 64,711,231 (+)	NCBI		T2T-CHM13v2.0

Raver2
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	4	100,926,235 - 101,009,567 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	4	100,926,180 - 101,009,567 (+)	Ensembl		GRCm39 Ensembl
GRCm38	4	101,069,038 - 101,152,370 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	4	101,068,983 - 101,152,370 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	4	100,741,643 - 100,824,975 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	4	100,566,970 - 100,650,302 (+)	NCBI		MGSCv36	mm8
Celera	4	99,414,495 - 99,495,069 (+)	NCBI		Celera
Cytogenetic Map	4	C6	NCBI
cM Map	4	45.98	NCBI

Raver2
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	5	120,796,807 - 120,898,281 (+)	NCBI		GRCr8
mRatBN7.2	5	115,700,985 - 115,780,465 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	5	115,701,326 - 115,778,792 (+)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	5	118,253,709 - 118,337,488 (+)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	5	119,979,075 - 120,062,854 (+)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	5	120,030,355 - 120,114,135 (+)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	5	119,903,449 - 119,982,723 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	5	119,903,507 - 119,981,047 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	5	123,786,053 - 123,865,081 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	5	121,724,573 - 121,802,690 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	5	121,729,812 - 121,793,494 (+)	NCBI
Celera	5	114,239,258 - 114,316,289 (+)	NCBI		Celera
Cytogenetic Map	5	q33	NCBI

Raver2
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955423	25,584,011 - 25,624,542 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955423	25,583,650 - 25,626,925 (-)	NCBI	ChiLan1.0	ChiLan1.0

RAVER2
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	1	162,026,302 - 162,115,036 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	1	161,177,050 - 161,265,918 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	1	63,994,827 - 64,083,565 (+)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	1	65,885,712 - 65,964,800 (+)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	1	65,881,633 - 65,970,360 (+)	Ensembl	panpan1.1		panPan2

RAVER2
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	5	45,408,569 - 45,536,316 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	5	45,410,284 - 45,499,762 (-)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	5	45,467,119 - 45,558,354 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	5	45,591,978 - 45,683,208 (-)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	5	45,591,982 - 45,683,396 (-)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	5	45,555,600 - 45,646,802 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	5	45,501,828 - 45,593,232 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	5	45,751,865 - 45,843,143 (-)	NCBI		UU_Cfam_GSD_1.0

Raver2
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024405058	77,890,039 - 77,982,729 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936692	2,211,583 - 2,274,700 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936692	2,205,462 - 2,298,964 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

RAVER2
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	6	147,567,182 - 147,722,407 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	6	147,566,930 - 147,722,428 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	6	135,984,056 - 136,063,037 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

RAVER2
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	20	68,253,358 - 68,338,928 (-)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	20	68,255,510 - 68,338,224 (-)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666033	49,186,939 - 49,272,893 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Raver2
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624742	29,726,270 - 29,782,050 (-)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624742	29,723,978 - 29,782,056 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in RAVER2
46 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 1p32.1-31.1(chr1:60473800-70944955)x1	copy number loss	See cases [RCV000050703]	Chr1:60473800..70944955 [GRCh38] Chr1:60939472..71410638 [GRCh37] Chr1:60712060..71183226 [NCBI36] Chr1:1p32.1-31.1	pathogenic
GRCh38/hg38 1p32.3-31.1(chr1:52595352-76767765)x3	copy number gain	See cases [RCV000051822]	Chr1:52595352..76767765 [GRCh38] Chr1:53061024..77233450 [GRCh37] Chr1:52833612..77006038 [NCBI36] Chr1:1p32.3-31.1	pathogenic
GRCh38/hg38 1p31.3(chr1:61922650-66445757)x3	copy number gain	See cases [RCV000051824]	Chr1:61922650..66445757 [GRCh38] Chr1:62388322..66911440 [GRCh37] Chr1:62160910..66684028 [NCBI36] Chr1:1p31.3	pathogenic
GRCh38/hg38 1p32.2-31.1(chr1:57350574-71325924)x1	copy number loss	See cases [RCV000053841]	Chr1:57350574..71325924 [GRCh38] Chr1:57816246..71791607 [GRCh37] Chr1:57588834..71564195 [NCBI36] Chr1:1p32.2-31.1	pathogenic
GRCh38/hg38 1p32.1-31.1(chr1:59632500-76730877)x1	copy number loss	See cases [RCV000053842]	Chr1:59632500..76730877 [GRCh38] Chr1:60098172..77196562 [GRCh37] Chr1:59870760..76969150 [NCBI36] Chr1:1p32.1-31.1	pathogenic
GRCh38/hg38 1p32.1-31.1(chr1:59760856-71578052)x1	copy number loss	See cases [RCV000133710]	Chr1:59760856..71578052 [GRCh38] Chr1:60226528..72043735 [GRCh37] Chr1:59999116..71816323 [NCBI36] Chr1:1p32.1-31.1	pathogenic
GRCh38/hg38 1p32.1-31.2(chr1:58819605-69107108)x1	copy number loss	See cases [RCV000134142]	Chr1:58819605..69107108 [GRCh38] Chr1:59285277..69572791 [GRCh37] Chr1:59057865..69345379 [NCBI36] Chr1:1p32.1-31.2	pathogenic
GRCh38/hg38 1p32.1-22.3(chr1:58819605-86098611)x1	copy number loss	See cases [RCV000136913]	Chr1:58819605..86098611 [GRCh38] Chr1:59285277..86564294 [GRCh37] Chr1:59057865..86336882 [NCBI36] Chr1:1p32.1-22.3	pathogenic
GRCh38/hg38 1p32.3-31.3(chr1:52787503-67339873)x3	copy number gain	See cases [RCV000141758]	Chr1:52787503..67339873 [GRCh38] Chr1:53253175..67805556 [GRCh37] Chr1:53025763..67578144 [NCBI36] Chr1:1p32.3-31.3	likely pathogenic
GRCh38/hg38 1p31.3-31.1(chr1:64072618-75518432)x3	copy number gain	See cases [RCV000142452]	Chr1:64072618..75518432 [GRCh38] Chr1:64538290..75984117 [GRCh37] Chr1:64310878..75756705 [NCBI36] Chr1:1p31.3-31.1	pathogenic
GRCh37/hg19 1p36.12-12(chr1:20608823-120546301)x3	copy number loss	not provided [RCV000762767]	Chr1:20608823..120546301 [GRCh37] Chr1:1p36.12-12	likely benign
NM_001366165.2(RAVER2):c.423T>G (p.Asp141Glu)	single nucleotide variant	not specified [RCV004299518]	Chr1:64777729 [GRCh38] Chr1:65243412 [GRCh37] Chr1:1p31.3	uncertain significance
GRCh37/hg19 1p31.3-31.1(chr1:63252828-77402595)x1	copy number loss	See cases [RCV000446378]	Chr1:63252828..77402595 [GRCh37] Chr1:1p31.3-31.1	pathogenic
GRCh37/hg19 1p31.3(chr1:61785602-67430956)x3	copy number gain	See cases [RCV000446769]	Chr1:61785602..67430956 [GRCh37] Chr1:1p31.3	pathogenic
GRCh37/hg19 1p36.33-q44(chr1:849467-249224684)x3	copy number gain	See cases [RCV000510383]	Chr1:849467..249224684 [GRCh37] Chr1:1p36.33-q44	pathogenic
GRCh37/hg19 1p31.3-22.3(chr1:64321264-88153669)x1	copy number loss	See cases [RCV000511392]	Chr1:64321264..88153669 [GRCh37] Chr1:1p31.3-22.3	pathogenic\|uncertain significance
GRCh37/hg19 1p36.33-q44(chr1:849467-249224684)	copy number gain	See cases [RCV000510926]	Chr1:849467..249224684 [GRCh37] Chr1:1p36.33-q44	pathogenic
NM_001366165.2(RAVER2):c.1710G>C (p.Leu570Phe)	single nucleotide variant	not specified [RCV004306220]	Chr1:64812767 [GRCh38] Chr1:65278450 [GRCh37] Chr1:1p31.3	uncertain significance
GRCh37/hg19 1p31.3-31.1(chr1:61351024-79583933)x1	copy number loss	See cases [RCV000512152]	Chr1:61351024..79583933 [GRCh37] Chr1:1p31.3-31.1	pathogenic
GRCh37/hg19 1p31.3(chr1:64848307-67436595)x1	copy number loss	not provided [RCV000684581]	Chr1:64848307..67436595 [GRCh37] Chr1:1p31.3	uncertain significance
GRCh37/hg19 1p31.3-31.1(chr1:62434799-71656180)x3	copy number gain	not provided [RCV000684577]	Chr1:62434799..71656180 [GRCh37] Chr1:1p31.3-31.1	pathogenic
GRCh37/hg19 1p31.3(chr1:62468555-65584629)x3	copy number gain	not provided [RCV000684578]	Chr1:62468555..65584629 [GRCh37] Chr1:1p31.3	uncertain significance
GRCh37/hg19 1p31.3(chr1:62830524-65396403)x1	copy number loss	not provided [RCV000684579]	Chr1:62830524..65396403 [GRCh37] Chr1:1p31.3	uncertain significance
GRCh37/hg19 1p36.33-q44(chr1:47851-249228449)x3	copy number gain	not provided [RCV000736295]	Chr1:47851..249228449 [GRCh37] Chr1:1p36.33-q44	pathogenic
GRCh37/hg19 1p36.33-q44(chr1:82154-249218992)x3	copy number gain	not provided [RCV000736305]	Chr1:82154..249218992 [GRCh37] Chr1:1p36.33-q44	pathogenic
GRCh37/hg19 1p36.22-21.1(chr1:103343285-103455144)x3	copy number gain	Global developmental delay [RCV000787285]	Chr1:103343285..103455144 [GRCh37] Chr1:1p36.22-21.1	uncertain significance
GRCh37/hg19 1p32.3-31.3(chr1:53675707-66644963)x1	copy number loss	Chromosome 1p32-p31 deletion syndrome [RCV001263218]	Chr1:53675707..66644963 [GRCh37] Chr1:1p32.3-31.3	pathogenic
NC_000001.10:g.(?_61548464)_(67861772_?)del	deletion	not provided [RCV003116397]	Chr1:61548464..67861772 [GRCh37] Chr1:1p31.3	pathogenic
NM_001366165.2(RAVER2):c.1391A>G (p.His464Arg)	single nucleotide variant	not specified [RCV004115213]	Chr1:64805085 [GRCh38] Chr1:65270768 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1600A>G (p.Asn534Asp)	single nucleotide variant	not specified [RCV004189927]	Chr1:64807394 [GRCh38] Chr1:65273077 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.154G>C (p.Glu52Gln)	single nucleotide variant	not specified [RCV004230970]	Chr1:64745326 [GRCh38] Chr1:65211009 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1455G>A (p.Met485Ile)	single nucleotide variant	not specified [RCV004111401]	Chr1:64807249 [GRCh38] Chr1:65272932 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.34G>A (p.Gly12Arg)	single nucleotide variant	not specified [RCV004112875]	Chr1:64745206 [GRCh38] Chr1:65210889 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1820A>G (p.Lys607Arg)	single nucleotide variant	not specified [RCV004214543]	Chr1:64814731 [GRCh38] Chr1:65280414 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.445G>A (p.Val149Met)	single nucleotide variant	not specified [RCV004163143]	Chr1:64777751 [GRCh38] Chr1:65243434 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.879C>A (p.Asp293Glu)	single nucleotide variant	not specified [RCV004157234]	Chr1:64781472 [GRCh38] Chr1:65247155 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1733G>A (p.Arg578Gln)	single nucleotide variant	not specified [RCV004180084]	Chr1:64812790 [GRCh38] Chr1:65278473 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.181A>T (p.Met61Leu)	single nucleotide variant	not specified [RCV004073511]	Chr1:64745353 [GRCh38] Chr1:65211036 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.97C>G (p.Pro33Ala)	single nucleotide variant	not specified [RCV004234358]	Chr1:64745269 [GRCh38] Chr1:65210952 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.355G>T (p.Ala119Ser)	single nucleotide variant	not specified [RCV004228463]	Chr1:64777661 [GRCh38] Chr1:65243344 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.34G>C (p.Gly12Arg)	single nucleotide variant	not specified [RCV004196320]	Chr1:64745206 [GRCh38] Chr1:65210889 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1732C>T (p.Arg578Trp)	single nucleotide variant	not specified [RCV004238943]	Chr1:64812789 [GRCh38] Chr1:65278472 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1549A>G (p.Met517Val)	single nucleotide variant	not specified [RCV004148780]	Chr1:64807343 [GRCh38] Chr1:65273026 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.272A>G (p.Asp91Gly)	single nucleotide variant	not specified [RCV004180868]	Chr1:64768678 [GRCh38] Chr1:65234361 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1865G>A (p.Ser622Asn)	single nucleotide variant	not specified [RCV004181329]	Chr1:64814776 [GRCh38] Chr1:65280459 [GRCh37] Chr1:1p31.3	likely benign
NM_001366165.2(RAVER2):c.1846G>T (p.Asp616Tyr)	single nucleotide variant	not specified [RCV004096810]	Chr1:64814757 [GRCh38] Chr1:65280440 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.350A>G (p.Gln117Arg)	single nucleotide variant	not specified [RCV004259607]	Chr1:64777656 [GRCh38] Chr1:65243339 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.965C>T (p.Ala322Val)	single nucleotide variant	not specified [RCV004341864]	Chr1:64781558 [GRCh38] Chr1:65247241 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.445G>C (p.Val149Leu)	single nucleotide variant	not specified [RCV004349210]	Chr1:64777751 [GRCh38] Chr1:65243434 [GRCh37] Chr1:1p31.3	likely benign
NM_001366165.2(RAVER2):c.644C>T (p.Ala215Val)	single nucleotide variant	not specified [RCV004354989]	Chr1:64777950 [GRCh38] Chr1:65243633 [GRCh37] Chr1:1p31.3	uncertain significance
GRCh37/hg19 1p32.1-31.3(chr1:60641326-65216639)x1	copy number loss	not specified [RCV003986418]	Chr1:60641326..65216639 [GRCh37] Chr1:1p32.1-31.3	pathogenic
NM_001366165.2(RAVER2):c.1451G>C (p.Gly484Ala)	single nucleotide variant	not specified [RCV004440933]	Chr1:64807245 [GRCh38] Chr1:65272928 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.28G>T (p.Gly10Cys)	single nucleotide variant	not specified [RCV004440936]	Chr1:64745200 [GRCh38] Chr1:65210883 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.532G>C (p.Val178Leu)	single nucleotide variant	not specified [RCV004440938]	Chr1:64777838 [GRCh38] Chr1:65243521 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1879G>A (p.Ala627Thr)	single nucleotide variant	not specified [RCV004440935]	Chr1:64814790 [GRCh38] Chr1:65280473 [GRCh37] Chr1:1p31.3	likely benign
NM_001366165.2(RAVER2):c.989A>G (p.Asn330Ser)	single nucleotide variant	not specified [RCV004440941]	Chr1:64789398 [GRCh38] Chr1:65255081 [GRCh37] Chr1:1p31.3	uncertain significance
NC_000001.10:g.(?_61548464)_(67861772_?)dup	duplication	PGM1-congenital disorder of glycosylation [RCV004584077]	Chr1:61548464..67861772 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.673T>G (p.Ser225Ala)	single nucleotide variant	not specified [RCV004660655]	Chr1:64777979 [GRCh38] Chr1:65243662 [GRCh37] Chr1:1p31.3	likely benign
NM_001366165.2(RAVER2):c.1741A>G (p.Lys581Glu)	single nucleotide variant	not specified [RCV004660656]	Chr1:64812798 [GRCh38] Chr1:65278481 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1756A>G (p.Asn586Asp)	single nucleotide variant	not specified [RCV004860618]	Chr1:64812813 [GRCh38] Chr1:65278496 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.742C>G (p.Leu248Val)	single nucleotide variant	not specified [RCV004860615]	Chr1:64778048 [GRCh38] Chr1:65243731 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1432C>G (p.Gln478Glu)	single nucleotide variant	not specified [RCV004860616]	Chr1:64807226 [GRCh38] Chr1:65272909 [GRCh37] Chr1:1p31.3	uncertain significance
GRCh37/hg19 1p34.1-22.2(chr1:44475302-89585894)x3	copy number gain	not provided [RCV004819297]	Chr1:44475302..89585894 [GRCh37] Chr1:1p34.1-22.2	pathogenic
NM_001366165.2(RAVER2):c.274T>C (p.Tyr92His)	single nucleotide variant	not specified [RCV004854487]	Chr1:64768680 [GRCh38] Chr1:65234363 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1574C>T (p.Ser525Leu)	single nucleotide variant	not specified [RCV004854488]	Chr1:64807368 [GRCh38] Chr1:65273051 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.355G>A (p.Ala119Thr)	single nucleotide variant	not specified [RCV004854489]	Chr1:64777661 [GRCh38] Chr1:65243344 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1711G>A (p.Gly571Arg)	single nucleotide variant	not specified [RCV004854492]	Chr1:64812768 [GRCh38] Chr1:65278451 [GRCh37] Chr1:1p31.3	uncertain significance
Single allele	deletion	Intellectual disability, severe [RCV000824954]	Chr1:59922631..72058653 [GRCh37] Chr1:1p32.1-31.1	pathogenic
GRCh37/hg19 1p31.3-31.2(chr1:65125111-69186543)	copy number gain	not specified [RCV002053380]	Chr1:65125111..69186543 [GRCh37] Chr1:1p31.3-31.2	uncertain significance
NM_001366165.2(RAVER2):c.236A>G (p.Asp79Gly)	single nucleotide variant	not specified [RCV004078724]	Chr1:64745408 [GRCh38] Chr1:65211091 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1928A>G (p.Gln643Arg)	single nucleotide variant	not specified [RCV004350155]	Chr1:64814839 [GRCh38] Chr1:65280522 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.494A>G (p.Tyr165Cys)	single nucleotide variant	not specified [RCV004440937]	Chr1:64777800 [GRCh38] Chr1:65243483 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.7G>A (p.Ala3Thr)	single nucleotide variant	not specified [RCV004440939]	Chr1:64745179 [GRCh38] Chr1:65210862 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.961A>G (p.Ile321Val)	single nucleotide variant	not specified [RCV004440940]	Chr1:64781554 [GRCh38] Chr1:65247237 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.925C>T (p.Pro309Ser)	single nucleotide variant	not specified [RCV004854490]	Chr1:64781518 [GRCh38] Chr1:65247201 [GRCh37] Chr1:1p31.3	uncertain significance
NM_001366165.2(RAVER2):c.1303G>A (p.Gly435Ser)	single nucleotide variant	not specified [RCV004854491]	Chr1:64804997 [GRCh38] Chr1:65270680 [GRCh37] Chr1:1p31.3	uncertain significance

Confirmed Target Of

miRNA Gene	Mature miRNA	Method Name	Result Type	Data Type	Support Type	PMID
MIR124-2	hsa-miR-124-3p	Mirtarbase	external_info	Microarray//qRT-PCR//qRT-PCR;Other	Functional MTI (Weak)	16549876
MIR99B	hsa-miR-99b-5p	Mirtarbase	external_info	Immunoprecipitaion//Luciferase reporter assay//Wes	Functional MTI	17637574
MIRLET7A2	hsa-let-7a-5p	Mirtarbase	external_info	Immunoprecipitaion//Luciferase reporter assay//Wes	Functional MTI	17637574
MIR99A	hsa-miR-99a-5p	Mirtarbase	external_info	Immunoprecipitaion//Luciferase reporter assay//Wes	Functional MTI	17637574
MIRLET7A1	hsa-let-7a-5p	Mirtarbase	external_info	Immunoprecipitaion//Luciferase reporter assay//Wes	Functional MTI	17637574

Predicted Target Of

	Summary Value
Count of predictions:	2641
Count of miRNA genes:	976
Interacting mature miRNAs:	1155
Transcripts:	ENST00000294428, ENST00000371072, ENST00000418058, ENST00000430964
Prediction methods:	Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
2314561	GLUCO47_H	Glucose level QTL 47 (human)	1.1		Glucose level		1	44773360	70773360	Human
1578602	LDLPS21_H	Low density lipoprotein particle size QTL 21 (human)	2.05	0.00037	LDL particle size		1	52531105	78531105	Human
597049284	GWAS1145358_H	glioma QTL GWAS1145358 (human)		0.000003	glioma		1	64763616	64763617	Human
597021174	GWAS1117248_H	central nervous system cancer, glioblastoma multiforme QTL GWAS1117248 (human)		2e-09	central nervous system integrity trait (VT:0010772)		1	64763616	64763617	Human
1578620	LDLPS20_H	Low density lipoprotein particle size QTL 21 (human)	2.04	0.00046	LDL particle size		1	52531105	78531105	Human
597129456	GWAS1225530_H	response to methotrexate, serum alanine aminotransferase measurement QTL GWAS1225530 (human)		4e-08	response to methotrexate, serum alanine aminotransferase measurement	serum alanine aminotransferase activity level (CMO:0000575)	1	64748329	64748330	Human
596979474	GWAS1098993_H	body height QTL GWAS1098993 (human)		3e-21	body height		1	64761190	64761191	Human
597144048	GWAS1240122_H	response to methotrexate, serum alanine aminotransferase measurement QTL GWAS1240122 (human)		0.000002	response to methotrexate, serum alanine aminotransferase measurement	serum alanine aminotransferase activity level (CMO:0000575)	1	64788297	64788298	Human
1578594	LDLPS19_H	Low density lipoprotein particle size QTL 19 (human)	2.56	0.00009	LDL particle size		1	52531105	78531105	Human
597021182	GWAS1117256_H	central nervous system cancer, glioma QTL GWAS1117256 (human)		4e-09	central nervous system integrity trait (VT:0010772)		1	64763616	64763617	Human
597049417	GWAS1145491_H	glioma QTL GWAS1145491 (human)		0.000001	glioma		1	64763616	64763617	Human

D1S2754

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	65,229,557 - 65,229,716	UniSTS	GRCh37
Build 36	1	65,002,145 - 65,002,304	RGD	NCBI36
Celera	1	63,520,448 - 63,520,607	RGD
Cytogenetic Map	1	p31.3	UniSTS
HuRef	1	63,338,511 - 63,338,670	UniSTS
Marshfield Genetic Map	1	98.21	UniSTS
Marshfield Genetic Map	1	98.21	RGD
Genethon Genetic Map	1	100.8	UniSTS
TNG Radiation Hybrid Map	1	36818.0	UniSTS
deCODE Assembly Map	1	91.61	UniSTS
Stanford-G3 RH Map	1	3286.0	UniSTS
Whitehead-YAC Contig Map	1		UniSTS
GeneMap99-G3 RH Map	1	3292.0	UniSTS

SHGC-74955

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	65,298,636 - 65,298,764	UniSTS	GRCh37
Build 36	1	65,071,224 - 65,071,352	RGD	NCBI36
Celera	1	63,589,522 - 63,589,650	RGD
Cytogenetic Map	1	p32.3-p31.3	UniSTS
Cytogenetic Map	1	p31.3	UniSTS
HuRef	1	63,407,545 - 63,407,673	UniSTS
TNG Radiation Hybrid Map	1	36888.0	UniSTS
GeneMap99-GB4 RH Map	1	174.74	UniSTS

G16069

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	65,261,890 - 65,262,032	UniSTS	GRCh37
Build 36	1	65,034,478 - 65,034,620	RGD	NCBI36
Celera	1	63,552,781 - 63,552,923	RGD
Cytogenetic Map	1	p31.3	UniSTS
HuRef	1	63,370,773 - 63,370,915	UniSTS

SHGC-107556

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	65,278,167 - 65,278,472	UniSTS	GRCh37
Build 36	1	65,050,755 - 65,051,060	RGD	NCBI36
Celera	1	63,569,057 - 63,569,362	RGD
Cytogenetic Map	1	p31.3	UniSTS
HuRef	1	63,387,088 - 63,387,393	UniSTS
TNG Radiation Hybrid Map	1	36854.0	UniSTS

SHGC-146900

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	65,295,924 - 65,296,214	UniSTS	GRCh37
Build 36	1	65,068,512 - 65,068,802	RGD	NCBI36
Celera	1	63,586,813 - 63,587,103	RGD
Cytogenetic Map	1	p31.3	UniSTS
HuRef	1	63,404,833 - 63,405,123	UniSTS
TNG Radiation Hybrid Map	1	36868.0	UniSTS

SHGC-74942

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	65,299,025 - 65,299,150	UniSTS	GRCh37
Build 36	1	65,071,613 - 65,071,738	RGD	NCBI36
Celera	1	63,589,911 - 63,590,036	RGD
Cytogenetic Map	1	p32.3-p31.3	UniSTS
Cytogenetic Map	1	p31.3	UniSTS
HuRef	1	63,407,934 - 63,408,059	UniSTS
TNG Radiation Hybrid Map	1	36882.0	UniSTS
GeneMap99-GB4 RH Map	1	174.11	UniSTS

SHGC-74945

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	65,296,845 - 65,297,020	UniSTS	GRCh37
Build 36	1	65,069,433 - 65,069,608	RGD	NCBI36
Celera	1	63,587,734 - 63,587,909	RGD
Cytogenetic Map	1	p31.3	UniSTS
HuRef	1	63,405,754 - 63,405,929	UniSTS
TNG Radiation Hybrid Map	1	36876.0	UniSTS
GeneMap99-GB4 RH Map	1	174.38	UniSTS

SHGC-56664

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	65,297,202 - 65,297,395	UniSTS	GRCh37
Build 36	1	65,069,790 - 65,069,983	RGD	NCBI36
Celera	1	63,588,091 - 63,588,284	RGD
Cytogenetic Map	1	p31.3	UniSTS
HuRef	1	63,406,111 - 63,406,304	UniSTS

RH66126

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	65,296,673 - 65,296,812	UniSTS	GRCh37
Build 36	1	65,069,261 - 65,069,400	RGD	NCBI36
Celera	1	63,587,562 - 63,587,701	RGD
Cytogenetic Map	1	p31.3	UniSTS
HuRef	1	63,405,582 - 63,405,721	UniSTS
GeneMap99-GB4 RH Map	1	174.38	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2438	2788	2253	4972	1726	2351	5	624	1727	465	2269	7081	6247	53	3733	1	852	1743	1617	174	1


RefSeq Transcripts	NM_001366165	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_018211	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011541706	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054337428	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_946693	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_946694	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AB046799	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC093427	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC099678	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK001632	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK058029	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK299228	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL359613	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC065303	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471059	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068277	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000294428 ⟹ ENSP00000294428

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	64,745,075 - 64,833,232 (+)	Ensembl

Ensembl Acc Id:

ENST00000371072 ⟹ ENSP00000360112

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	64,745,095 - 64,833,232 (+)	Ensembl

Ensembl Acc Id:

ENST00000418058 ⟹ ENSP00000397069

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	64,778,066 - 64,816,509 (+)	Ensembl

RefSeq Acc Id:

NM_001366165 ⟹ NP_001353094

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	64,745,075 - 64,833,232 (+)	NCBI
T2T-CHM13v2.0	1	64,623,084 - 64,711,231 (+)	NCBI

Sequence:

show sequence

CTCTGCCCGCCTCGCCCTCGCCCGGGCCTCCTCCCGCTTTCTCTCTCCGCTTCCCCTGGAGCCTCCGAGGAGTCCGCAGCCGCTGGGCGCCCGGGAAGATGGCGGCGGCGGCGGGAGACGGCGGCGGC
GAGGGGGGCGCGGGCCTGGGCAGCGCGGCGGGGCTGGGGCCGGGGCCGGGGCTGCGCGGGCAGGGCCCCTCAGCCGAAGCGCACGAGGGCGCCCCGGACCCGATGCCCGCCGCGCTGCACCCTGAGGA
GGTCGCCGCGCGACTGCAGCGGATGCAGCGGGAGCTGAGCAACCGCAGGAAAATCCTGGTGAAAAACCTGCCCCAGGACAGCAACTGCCAGGAAGTTCATGATTTGTTAAAAGACTATGACTTAAAAT
ATTGTTATGTGGACAGAAATAAACGAACAGCTTTTGTTACCTTATTGAATGGGGAACAAGCCCAGAACGCAATTCAGATGTTTCATCAATATTCTTTTAGAGGAAAAGACTTAATAGTCCAGCTTCAG
CCAACAGATGCTTTGTTGTGTATTACCAACGTGCCCATTTCTTTTACATCAGAAGAGTTTGAAGAACTTGTTCGTGCTTATGGAAATATTGAGAGATGTTTTCTGGTCTATAGTGAAGTTACTGGCCA
TTCCAAAGGCTATGGATTTGTGGAATACATGAAAAAGGACTTTGCTGCAAAGGCTAGACTGGAGCTATTGGGTAGACAGTTGGGAGCATCAGCACTCTTTGCACAATGGATGGATGTTAATCTATTGG
CTTCAGAGCTCATTCATTCTAAGTGCCTTTGTATTGATAAACTCCCCAGTGACTACAGGGATTCAGAAGAGCTGTTGCAAATTTTTTCCAGTGTCCATAAACCTGTGTTTTGCCAGCTTGCACAGGAT
GAAGGTAGTTACGTTGGTGGCTTTGCAGTGGTTGAATATAGCACTGCGGAGCAGGCTGAAGAGGTCCAGCAGGCAGCAGACGGTATGACCATCAAGGGCAGCAAAGTCCAGGTTTCCTTCTGTGCTCC
TGGAGCGCCAGGGCGAAGTACATTAGCAGCATTGATAGCGGCTCAACGTGTGATGCACAGTAATCAAAAGGGCTTACTTCCAGAGCCAAATCCAGTACAAATTATGAAAAGTTTAAACAACCCTGCCA
TGTTGCAAGTTCTTCTACAGCCCCAGTTATGTGGACGAGCTGTTAAACCAGCCGTTCTTGGAACACCTCACAGCTTGCCACATCTGATGAATCCATCCATCTCTCCTGCATTTTTACATTTGAATAAA
GCACATCAGAGCTCAGTTATGGGTAATACTTCTAATTTATTCCTTCAGAATCTTTCTCATATACCACTGGCACAACAACAATTAATGAAGTTTGAGAATATTCATACTAATAATAAACCCGGCTTACT
TGGAGAGCCCCCAGCTGTGGTACTTCAGACTGCACTAGGGATAGGGTCAGTGCTTCCATTGAAAAAGGAGTTGGGACATCATCATGGAGAAGCACATAAAACATCTAGCCTGATTCCAACTCAAACAA
CGATAACAGCTGGAATGGGCATGTTACCATTCTTTCCAAATCAGCACATTGCTGGACAGGCTGGGCCAGGGCACAGTAATACTCAGGAGAAACAGCCAGCCACGGTGGGAATGGCAGAAGGAAATTTC
TCAGGGTCGCAGCCTTATCTTCAGAGCTTTCCAAACCTTGCTGCTGGAAGCTTGCTGGTGGGACACCATAAGCAGCAGCAAAGCCAGCCAAAAGGCACAGAGATAAGTTCAGGGGCTGCCTCTAAGAA
TCAAACTTCACTCTTGGGAGAACCACCAAAAGAAATTCGGCTCAGTAAAAATCCATACTTGAATTTGGCAAGTGTGTTGCCCAGTGTGTGCTTATCATCCCCTGCAAGTAAAACCACTCTTCATAAGA
CTGGAATTGCAAGCAGCATTCTGGATGCAATCTCTCAGGGAAGTGAATCACAACACGCATTGGAAAAGTGCATTGCTTATTCTCCACCTTTTGGTGATTATGCACAGGTGTCATCTTTAAGAAATGAA
AAGCGAGGCTCATCATATCTCATCTCTGCCCCAGAAGGTGGTTCAGTGGAATGTGTTGACCAGCATTCTCAGGGCACAGGAGCATATTACATGGAAACTTACTTAAAAAAGAAGCGAGTATACTGAGT
TAAGCTCTCTCCTAATAACCCCCTAAGGTTCTCTGCAGTATCTCTGCTGTTCATCGCTGCCTTAACTTCATTCAAACTAGCCATATCCTTTAAATACGGGTTTATAGTTTCCCAGAAGGAACTGTGTT
GTGCAGCAGGCAGAAATGCCAAATAAAAAATAGCAATAAGAAGAGACATCAATTGAGGACATTTTCCACTAGAGTCAGATGCATCTTAATCAGTGTGCTAACTTACAATCCATTGGAGAAACTAACAA
TGTTCCAATATTCCTTGATTTAGGACTGGGAATAATTCTGACACCATATATAAAAGAAGTTTGAAGCAATAAATGGGAAACAGTGTTGTTTCCTGAGCCTTAGAAGAATGAGTTTCTTATAAGCCAAT
GTGCATTTCAATTTACTTTCCCTAGAAGTAATTGCATTTATAGATTTTTAGGACTTTTCCTAGAACTACAAGGGTGCAAGTACCAAATGTGCTGATGGTAATATTATAAAGATGCTCTACATGCACAC
TCAATTACGCCCACACCAGCCATGCAAAATTAAACCCGGTAAGAGAGTGACAGTGATATCCAAGGTATCCACTACTACCGATGCTTTAAGATGTTGTTTACCATTTATACCTTCTGTGAAAAATAGAA
GGTATTTTAAGAAAAGTAACTTTGGTGATCTAATAAAAGGGTTTGGCAAACTACACCCTGGGTCCACATTTGGTCTACCACCCGCTTTTGTGCTGCCTGCAAGCTAAGACTAATGTTTACATTTTTAA
ATGGTTGGAGGAAAAAAGAAAACTTATGACATGAAATTTATATGAAATTCAGATTTCAGTGTCCATAAATAAACTTTTATTGGGACGTTGCCATGCTCATTCATTTACGTGTTGTCTGTGGCACTCTT
ACGCTACAAGGGCAGAACTGATTAGCTTCAACAGAGACTGTATGGCCTACAAAGACCATATGGCCTAAAATTTCAAGTATCTGGCCATTTATATATAGTTTGCTGATCCCTGATCTAATAGCACTAAT
TCTAATAGCAACTATTCCTTTCAATTCACCTAAAGACAGACCTTTAGCCTTTAGACAGACTTGTAAGTGGAAAGGAACATGGGTTTCTGTGCTCATTTCATAGCGTAGACTAGTAATGATCTAATGAC
TAGAATGGGGCCTATTTTGATCACTAAATGCCCTATTATTTCCACAATATAGTATAGTAAAGCAGTCAATACTGCACTTTCTGATGGAGTCTTAAGGAGTCACAGTATTTATAACCATTTTGAGCTAA
TAAGCTATACCTCACTCTCTGCTTTCTCTCTCACTCTTTTTGATAGTGTGTTAGGGTGAAAAATCAGTTATTTAACCCAATTTACTTGTGAAAGAAGTTTTATCTTTATGGACTATGATGACTTTTGA
CATCACCATTTCTTGAAGACCTTGGTATTAAATGCATGAGAAACCTTTTGCCATCTAGAAATTTCTAAGTTTGTTTATGTTATAAGACTGTAATTAATTGATAGGGAATTTGGGATCTCAATCCGGGG
CTTTTTGAAATCAGATCATTAAATATCTCGTCACTTTGGGGACTTGTTATTTTTAACTATGATGTGGATATCCTGTTTTAATTATGAAGTCTAGAATTGGTACATATGTTGTATGCTTTGTAAAGAAT
TTCACTTGGTCTAATTTATTGCATATACTAGCTTCTGTTGGAAAATGACTGACAGCTAGAAAGTTTAAGGTAATTTCTAAGTATACTACCTATAAGTAACTGATAAGAATTAGGCATCATTCAGTGAT
ATAGCAGATGACTAATGGGTTTTTCAGGCCCTGCACTTCTCTTTCCCATTTTCCTGTTGCATTCAGCCTCTTCAATGCTTAGTCACACCTCCACTATAGTACAAACAAACAAACAAACAGAAGAAAGG
AAAGATGGTGAATTTTGCAACAGAGCTGCAAAAAGTCAGTCAGTCAAAGCAGGAAGAGGTTGAAGGAACTAAAACAAACAAACAAAGGTGTCTGGACTACAGCACAGTGGACATGCCATCCATACTGG
CCTGTGCCCCGTTATCAATCACTGGGCACAACAGTGAAGAAGTGCAAATCAAGTGGTGTTTGTTTGTTTGTTAGTAGTAAGGACCGTAACCCACCCCTTCCTCCCCCCAAAACTATACTGTTATTTTT
CTATGTAAGCAAATTGTTTGAAATGCTTTGAAAATGAAATCTTAATATTAAAAGGCATATGCATGTAAA

hide sequence

RefSeq Acc Id:

NM_018211 ⟹ NP_060681

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	64,745,075 - 64,833,232 (+)	NCBI
GRCh37	1	65,210,778 - 65,298,915 (+)	RGD
Build 36	1	64,983,366 - 65,071,500 (+)	NCBI Archive
Celera	1	63,501,670 - 63,589,801 (+)	RGD
HuRef	1	63,319,747 - 63,407,824 (+)	ENTREZGENE
CHM1_1	1	65,327,123 - 65,415,262 (+)	NCBI
T2T-CHM13v2.0	1	64,623,084 - 64,711,231 (+)	NCBI

Sequence:

show sequence

CTCTGCCCGCCTCGCCCTCGCCCGGGCCTCCTCCCGCTTTCTCTCTCCGCTTCCCCTGGAGCCTCCGAGGAGTCCGCAGCCGCTGGGCGCCCGGGAAGATGGCGGCGGCGGCGGGAGACGGCGGCGGC
GAGGGGGGCGCGGGCCTGGGCAGCGCGGCGGGGCTGGGGCCGGGGCCGGGGCTGCGCGGGCAGGGCCCCTCAGCCGAAGCGCACGAGGGCGCCCCGGACCCGATGCCCGCCGCGCTGCACCCTGAGGA
GGTCGCCGCGCGACTGCAGCGGATGCAGCGGGAGCTGAGCAACCGCAGGAAAATCCTGGTGAAAAACCTGCCCCAGGACAGCAACTGCCAGGAAGTTCATGATTTGTTAAAAGACTATGACTTAAAAT
ATTGTTATGTGGACAGAAATAAACGAACAGCTTTTGTTACCTTATTGAATGGGGAACAAGCCCAGAACGCAATTCAGATGTTTCATCAATATTCTTTTAGAGGAAAAGACTTAATAGTCCAGCTTCAG
CCAACAGATGCTTTGTTGTGTATTACCAACGTGCCCATTTCTTTTACATCAGAAGAGTTTGAAGAACTTGTTCGTGCTTATGGAAATATTGAGAGATGTTTTCTGGTCTATAGTGAAGTTACTGGCCA
TTCCAAAGGCTATGGATTTGTGGAATACATGAAAAAGGACTTTGCTGCAAAGGCTAGACTGGAGCTATTGGGTAGACAGTTGGGAGCATCAGCACTCTTTGCACAATGGATGGATGTTAATCTATTGG
CTTCAGAGCTCATTCATTCTAAGTGCCTTTGTATTGATAAACTCCCCAGTGACTACAGGGATTCAGAAGAGCTGTTGCAAATTTTTTCCAGTGTCCATAAACCTGTGTTTTGCCAGCTTGCACAGGAT
GAAGGTAGTTACGTTGGTGGCTTTGCAGTGGTTGAATATAGCACTGCGGAGCAGGCTGAAGAGGTCCAGCAGGCAGCAGACGGTATGACCATCAAGGGCAGCAAAGTCCAGGTTTCCTTCTGTGCTCC
TGGAGCGCCAGGGCGAAGTACATTAGCAGCATTGATAGCGGCTCAACGTGTGATGCACAGTAATCAAAAGGGCTTACTTCCAGAGCCAAATCCAGTACAAATTATGAAAAGTTTAAACAACCCTGCCA
TGTTGCAAGTTCTTCTACAGCCCCAGTTATGTGGACGAGCTGTTAAACCAGCCGTTCTTGGAACACCTCACAGCTTGCCACATCTGATGAATCCATCCATCTCTCCTGCATTTTTACATTTGAATAAA
GCACATCAGAATCTTTCTCATATACCACTGGCACAACAACAATTAATGAAGTTTGAGAATATTCATACTAATAATAAACCCGGCTTACTTGGAGAGCCCCCAGCTGTGGTACTTCAGACTGCACTAGG
GATAGGGTCAGTGCTTCCATTGAAAAAGGAGTTGGGACATCATCATGGAGAAGCACATAAAACATCTAGCCTGATTCCAACTCAAACAACGATAACAGCTGGAATGGGCATGTTACCATTCTTTCCAA
ATCAGCACATTGCTGGACAGGCTGGGCCAGGGCACAGTAATACTCAGGAGAAACAGCCAGCCACGGTGGGAATGGCAGAAGGAAATTTCTCAGGGTCGCAGCCTTATCTTCAGAGCTTTCCAAACCTT
GCTGCTGGAAGCTTGCTGGTGGGACACCATAAGCAGCAGCAAAGCCAGCCAAAAGGCACAGAGATAAGTTCAGGGGCTGCCTCTAAGAATCAAACTTCACTCTTGGGAGAACCACCAAAAGAAATTCG
GCTCAGTAAAAATCCATACTTGAATTTGGCAAGTGTGTTGCCCAGTGTGTGCTTATCATCCCCTGCAAGTAAAACCACTCTTCATAAGACTGGAATTGCAAGCAGCATTCTGGATGCAATCTCTCAGG
GAAGTGAATCACAACACGCATTGGAAAAGTGCATTGCTTATTCTCCACCTTTTGGTGATTATGCACAGGTGTCATCTTTAAGAAATGAAAAGCGAGGCTCATCATATCTCATCTCTGCCCCAGAAGGT
GGTTCAGTGGAATGTGTTGACCAGCATTCTCAGGGCACAGGAGCATATTACATGGAAACTTACTTAAAAAAGAAGCGAGTATACTGAGTTAAGCTCTCTCCTAATAACCCCCTAAGGTTCTCTGCAGT
ATCTCTGCTGTTCATCGCTGCCTTAACTTCATTCAAACTAGCCATATCCTTTAAATACGGGTTTATAGTTTCCCAGAAGGAACTGTGTTGTGCAGCAGGCAGAAATGCCAAATAAAAAATAGCAATAA
GAAGAGACATCAATTGAGGACATTTTCCACTAGAGTCAGATGCATCTTAATCAGTGTGCTAACTTACAATCCATTGGAGAAACTAACAATGTTCCAATATTCCTTGATTTAGGACTGGGAATAATTCT
GACACCATATATAAAAGAAGTTTGAAGCAATAAATGGGAAACAGTGTTGTTTCCTGAGCCTTAGAAGAATGAGTTTCTTATAAGCCAATGTGCATTTCAATTTACTTTCCCTAGAAGTAATTGCATTT
ATAGATTTTTAGGACTTTTCCTAGAACTACAAGGGTGCAAGTACCAAATGTGCTGATGGTAATATTATAAAGATGCTCTACATGCACACTCAATTACGCCCACACCAGCCATGCAAAATTAAACCCGG
TAAGAGAGTGACAGTGATATCCAAGGTATCCACTACTACCGATGCTTTAAGATGTTGTTTACCATTTATACCTTCTGTGAAAAATAGAAGGTATTTTAAGAAAAGTAACTTTGGTGATCTAATAAAAG
GGTTTGGCAAACTACACCCTGGGTCCACATTTGGTCTACCACCCGCTTTTGTGCTGCCTGCAAGCTAAGACTAATGTTTACATTTTTAAATGGTTGGAGGAAAAAAGAAAACTTATGACATGAAATTT
ATATGAAATTCAGATTTCAGTGTCCATAAATAAACTTTTATTGGGACGTTGCCATGCTCATTCATTTACGTGTTGTCTGTGGCACTCTTACGCTACAAGGGCAGAACTGATTAGCTTCAACAGAGACT
GTATGGCCTACAAAGACCATATGGCCTAAAATTTCAAGTATCTGGCCATTTATATATAGTTTGCTGATCCCTGATCTAATAGCACTAATTCTAATAGCAACTATTCCTTTCAATTCACCTAAAGACAG
ACCTTTAGCCTTTAGACAGACTTGTAAGTGGAAAGGAACATGGGTTTCTGTGCTCATTTCATAGCGTAGACTAGTAATGATCTAATGACTAGAATGGGGCCTATTTTGATCACTAAATGCCCTATTAT
TTCCACAATATAGTATAGTAAAGCAGTCAATACTGCACTTTCTGATGGAGTCTTAAGGAGTCACAGTATTTATAACCATTTTGAGCTAATAAGCTATACCTCACTCTCTGCTTTCTCTCTCACTCTTT
TTGATAGTGTGTTAGGGTGAAAAATCAGTTATTTAACCCAATTTACTTGTGAAAGAAGTTTTATCTTTATGGACTATGATGACTTTTGACATCACCATTTCTTGAAGACCTTGGTATTAAATGCATGA
GAAACCTTTTGCCATCTAGAAATTTCTAAGTTTGTTTATGTTATAAGACTGTAATTAATTGATAGGGAATTTGGGATCTCAATCCGGGGCTTTTTGAAATCAGATCATTAAATATCTCGTCACTTTGG
GGACTTGTTATTTTTAACTATGATGTGGATATCCTGTTTTAATTATGAAGTCTAGAATTGGTACATATGTTGTATGCTTTGTAAAGAATTTCACTTGGTCTAATTTATTGCATATACTAGCTTCTGTT
GGAAAATGACTGACAGCTAGAAAGTTTAAGGTAATTTCTAAGTATACTACCTATAAGTAACTGATAAGAATTAGGCATCATTCAGTGATATAGCAGATGACTAATGGGTTTTTCAGGCCCTGCACTTC
TCTTTCCCATTTTCCTGTTGCATTCAGCCTCTTCAATGCTTAGTCACACCTCCACTATAGTACAAACAAACAAACAAACAGAAGAAAGGAAAGATGGTGAATTTTGCAACAGAGCTGCAAAAAGTCAG
TCAGTCAAAGCAGGAAGAGGTTGAAGGAACTAAAACAAACAAACAAAGGTGTCTGGACTACAGCACAGTGGACATGCCATCCATACTGGCCTGTGCCCCGTTATCAATCACTGGGCACAACAGTGAAG
AAGTGCAAATCAAGTGGTGTTTGTTTGTTTGTTAGTAGTAAGGACCGTAACCCACCCCTTCCTCCCCCCAAAACTATACTGTTATTTTTCTATGTAAGCAAATTGTTTGAAATGCTTTGAAAATGAAA
TCTTAATATTAAAAGGCATATGCATGTAAA

hide sequence

RefSeq Acc Id:

XM_011541706 ⟹ XP_011540008

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	64,745,075 - 64,812,843 (+)	NCBI

Sequence:

show sequence

CCTCTCCCCGCCAGCAGGCTGCTGGCTGCGGCGCCGCCTCTCTCTACTCCCTCCTCCCACCGCC
CCCCTTCCCCGCGGTTGGGCCCACTCTGCGGCCTCTGCCCGCCTCGCCCTCGCCCGGGCCTCCTCCCGCTTTCTCTCTCCGCTTCCCCTGGAGCCTCCGAGGAGTCCGCAGCCGCTGGGCGCCCGGGA
AGATGGCGGCGGCGGCGGGAGACGGCGGCGGCGAGGGGGGCGCGGGCCTGGGCAGCGCGGCGGGGCTGGGGCCGGGGCCGGGGCTGCGCGGGCAGGGCCCCTCAGCCGAAGCGCACGAGGGCGCCCCG
GACCCGATGCCCGCCGCGCTGCACCCTGAGGAGGTCGCCGCGCGACTGCAGCGGATGCAGCGGGAGCTGAGCAACCGCAGGAAAATCCTGGTGAAAAACCTGCCCCAGGACAGCAACTGCCAGGAAGT
TCATGATTTGTTAAAAGACTATGACTTAAAATATTGTTATGTGGACAGAAATAAACGAACAGCTTTTGTTACCTTATTGAATGGGGAACAAGCCCAGAACGCAATTCAGATGTTTCATCAATATTCTT
TTAGAGGAAAAGACTTAATAGTCCAGCTTCAGCCAACAGATGCTTTGTTGTGTATTACCAACGTGCCCATTTCTTTTACATCAGAAGAGTTTGAAGAACTTGTTCGTGCTTATGGAAATATTGAGAGA
TGTTTTCTGGTCTATAGTGAAGTTACTGGCCATTCCAAAGGCTATGGATTTGTGGAATACATGAAAAAGGACTTTGCTGCAAAGGCTAGACTGGAGCTATTGGGTAGACAGTTGGGAGCATCAGCACT
CTTTGCACAATGGATGGATGTTAATCTATTGGCTTCAGAGCTCATTCATTCTAAGTGCCTTTGTATTGATAAACTCCCCAGTGACTACAGGGATTCAGAAGAGCTGTTGCAAATTTTTTCCAGTGTCC
ATAAACCTGTGTTTTGCCAGCTTGCACAGGATGAAGGTAGTTACGTTGGTGGCTTTGCAGTGGTTGAATATAGCACTGCGGAGCAGGCTGAAGAGGTCCAGCAGGCAGCAGACGGTATGACCATCAAG
GGCAGCAAAGTCCAGGTTTCCTTCTGTGCTCCTGGAGCGCCAGGGCGAAGTACATTAGCAGCATTGATAGCGGCTCAACGTGTGATGCACAGTAATCAAAAGGGCTTACTTCCAGAGCCAAATCCAGT
ACAAATTATGAAAAGTTTAAACAACCCTGCCATGTTGCAAGTTCTTCTACAGCCCCAGTTATGTGGACGAGCTGTTAAACCAGCCGTTCTTGGAACACCTCACAGCTTGCCACATCTGATGAATCCAT
CCATCTCTCCTGCATTTTTACATTTGAATAAAGCACATCAGAGCTCAGTTATGGGTAATACTTCTAATTTATTCCTTCAGAATCTTTCTCATATACCACTGGCACAACAACAATTAATGAAGTTTGAG
AATATTCATACTAATAATAAACCCGGCTTACTTGGAGAGCCCCCAGCTGTGGTACTTCAGACTGCACTAGGGATAGGGTCAGTGCTTCCATTGAAAAAGGAGTTGGGACATCATCATGGAGAAGCACA
TAAAAGCTGCCTCTAAGAATCAAACTTCACTCTTGGGAGAACCACCAAAAGAAATTCGGCTCAGTAAAAATCCATACTTGAATTTGGCAAGTGTGTTGCCCAGTGTGTGCT

hide sequence

RefSeq Acc Id:

XM_054337428 ⟹ XP_054193403

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	1	64,623,084 - 64,690,867 (+)	NCBI


Protein RefSeqs	NP_001353094	(Get FASTA)	NCBI Sequence Viewer
	NP_060681	(Get FASTA)	NCBI Sequence Viewer
	XP_011540008	(Get FASTA)	NCBI Sequence Viewer
	XP_054193403	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAH65303	(Get FASTA)	NCBI Sequence Viewer
	BAA91798	(Get FASTA)	NCBI Sequence Viewer
	BAB13405	(Get FASTA)	NCBI Sequence Viewer
	BAG61261	(Get FASTA)	NCBI Sequence Viewer
	CAB94883	(Get FASTA)	NCBI Sequence Viewer
	EAX06549	(Get FASTA)	NCBI Sequence Viewer
	EAX06550	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000294428
	ENSP00000294428.3
	ENSP00000360112
	ENSP00000360112.4
GenBank Protein	Q9HCJ3	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:	NP_060681 ⟸ NM_018211
- Peptide Label:	isoform 2
- UniProtKB:	Q9HCJ3 (UniProtKB/Swiss-Prot)
- Sequence:	show sequence MAAAAGDGGGEGGAGLGSAAGLGPGPGLRGQGPSAEAHEGAPDPMPAALHPEEVAARLQRMQRELSNRRKILVKNLPQDSNCQEVHDLLKDYDLKYCYVDRNKRTAFVTLLNGEQAQNAIQMFHQYSF RGKDLIVQLQPTDALLCITNVPISFTSEEFEELVRAYGNIERCFLVYSEVTGHSKGYGFVEYMKKDFAAKARLELLGRQLGASALFAQWMDVNLLASELIHSKCLCIDKLPSDYRDSEELLQIFSSVH KPVFCQLAQDEGSYVGGFAVVEYSTAEQAEEVQQAADGMTIKGSKVQVSFCAPGAPGRSTLAALIAAQRVMHSNQKGLLPEPNPVQIMKSLNNPAMLQVLLQPQLCGRAVKPAVLGTPHSLPHLMNPS ISPAFLHLNKAHQNLSHIPLAQQQLMKFENIHTNNKPGLLGEPPAVVLQTALGIGSVLPLKKELGHHHGEAHKTSSLIPTQTTITAGMGMLPFFPNQHIAGQAGPGHSNTQEKQPATVGMAEGNFSGS QPYLQSFPNLAAGSLLVGHHKQQQSQPKGTEISSGAASKNQTSLLGEPPKEIRLSKNPYLNLASVLPSVCLSSPASKTTLHKTGIASSILDAISQGSESQHALEKCIAYSPPFGDYAQVSSLRNEKRG SSYLISAPEGGSVECVDQHSQGTGAYYMETYLKKKRVY hide sequence

RefSeq Acc Id:

XP_011540008 ⟸ XM_011541706

- Peptide Label:

isoform X1

- Sequence:

show sequence

MAAAAGDGGGEGGAGLGSAAGLGPGPGLRGQGPSAEAHEGAPDPMPAALHPEEVAARLQRMQRE
LSNRRKILVKNLPQDSNCQEVHDLLKDYDLKYCYVDRNKRTAFVTLLNGEQAQNAIQMFHQYSFRGKDLIVQLQPTDALLCITNVPISFTSEEFEELVRAYGNIERCFLVYSEVTGHSKGYGFVEYMK
KDFAAKARLELLGRQLGASALFAQWMDVNLLASELIHSKCLCIDKLPSDYRDSEELLQIFSSVHKPVFCQLAQDEGSYVGGFAVVEYSTAEQAEEVQQAADGMTIKGSKVQVSFCAPGAPGRSTLAAL
IAAQRVMHSNQKGLLPEPNPVQIMKSLNNPAMLQVLLQPQLCGRAVKPAVLGTPHSLPHLMNPSISPAFLHLNKAHQSSVMGNTSNLFLQNLSHIPLAQQQLMKFENIHTNNKPGLLGEPPAVVLQTA
LGIGSVLPLKKELGHHHGEAHKSCL

hide sequence

RefSeq Acc Id:	NP_001353094 ⟸ NM_001366165
- Peptide Label:	isoform 1
- UniProtKB:	Q9HCJ3 (UniProtKB/Swiss-Prot), Q6P141 (UniProtKB/Swiss-Prot), Q9NPV7 (UniProtKB/Swiss-Prot)

Ensembl Acc Id:

ENSP00000360112 ⟸ ENST00000371072

Ensembl Acc Id:

ENSP00000294428 ⟸ ENST00000294428

Protein Domains

RRM

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q9HCJ3-F1-model_v2	AlphaFold	Q9HCJ3	1-691	view protein structure

RGD ID:

6855768

Promoter ID:

EPDNEW_H1049

Type:

initiation region

Name:

RAVER2_2

Description:

ribonucleoprotein, PTB binding 2

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H1050

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	64,744,973 - 64,745,033	EPDNEW

RGD ID:

6855770

Promoter ID:

EPDNEW_H1050

Type:

initiation region

Name:

RAVER2_1

Description:

ribonucleoprotein, PTB binding 2

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H1049

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	64,745,075 - 64,745,135	EPDNEW

RGD ID:

6786395

Promoter ID:

HG_KWN:3085

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, HeLa_S3, K562, NB4

Transcripts:

ENST00000294428, ENST00000371072

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	1	64,983,066 - 64,983,566 (+)	MPROMDB

Database	Acc Id	Source(s)
COSMIC	RAVER2	COSMIC
Ensembl Genes	ENSG00000162437	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000294428	ENTREZGENE
	ENST00000294428.8	UniProtKB/Swiss-Prot
	ENST00000371072	ENTREZGENE
	ENST00000371072.8	UniProtKB/Swiss-Prot
Gene3D-CATH	3.30.70.330	UniProtKB/Swiss-Prot
GTEx	ENSG00000162437	GTEx
HGNC ID	HGNC:25577	ENTREZGENE
Human Proteome Map	RAVER2	Human Proteome Map
InterPro	Euk_RNA-bind_prot	UniProtKB/Swiss-Prot
	Nucleotide-bd_a/b_plait_sf	UniProtKB/Swiss-Prot
	RAVER2	UniProtKB/Swiss-Prot
	RAVER2_RRM1	UniProtKB/Swiss-Prot
	RAVER2_RRM3	UniProtKB/Swiss-Prot
	RBD_domain_sf	UniProtKB/Swiss-Prot
	RRM_dom	UniProtKB/Swiss-Prot
KEGG Report	hsa:55225	UniProtKB/Swiss-Prot
NCBI Gene	55225	ENTREZGENE
OMIM	609953	OMIM
PANTHER	OS02G0815200 PROTEIN	UniProtKB/Swiss-Prot
	RRM DOMAIN-CONTAINING PROTEIN	UniProtKB/Swiss-Prot
Pfam	RRM_1	UniProtKB/Swiss-Prot
PharmGKB	PA144596391	PharmGKB
PROSITE	RRM	UniProtKB/Swiss-Prot
SMART	RRM	UniProtKB/Swiss-Prot
Superfamily-SCOP	SSF54928	UniProtKB/Swiss-Prot
UniProt	E9PE10_HUMAN	UniProtKB/TrEMBL
	Q6P141	ENTREZGENE
	Q9HCJ3	ENTREZGENE
	Q9NPV7	ENTREZGENE
	RAVR2_HUMAN	UniProtKB/Swiss-Prot
UniProt Secondary	Q6P141	UniProtKB/Swiss-Prot
	Q9NPV7	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2016-04-12	RAVER2	ribonucleoprotein, PTB binding 2		ribonucleoprotein, PTB-binding 2	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

Imported Human Phenotype Annotations - ClinVar

Send us a Message

Imported Disease Annotations - ClinVar

Imported Human Phenotype Annotations - ClinVar